Belzutifan/MK-6482 per il trattamento di Feocromocitoma/Paraganglioma (PPGL) Avanzato, Tumore Neuroendocrino Pancreatico, Tumori associati alla Malattia di Von Hippel-Lindau (VHL), Tumore Stromale Gastrointestinale Avanzato, o tumori solidi avanzati con alterazioni genetiche correlate a HIF-2α.

This is a study to evaluate the efficacy and safety of belzutifan monotherapy in participants with advanced pheochromocytoma/paraganglioma (PPGL), pancreatic neuroendocrine tumor (pNET), von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal